SCHEDULE 13G/A: T. Rowe Price Amends CTS CORP Stake to 1.8%
Beneficial Ownership Report (Schedule 13G Amendment)
T. Rowe Price Investment Management, Inc. has filed an amendment to its Schedule 13G, reporting a 1.8% beneficial ownership stake in CTS CORP as of September 30, 2025.
Summary
- T. Rowe Price Investment Management, Inc. reported beneficial ownership of 542,682 shares of CTS CORP common stock.
- This ownership represents 1.8% of the total class of CTS CORP securities.
- The filing is an Amendment No. 5 to a Schedule 13G, indicating a previous filing for this stake.
- T. Rowe Price Investment Management, Inc. holds sole voting power over all 542,682 shares.
- T. Rowe Price Investment Management, Inc. holds sole dispositive power over all 542,682 shares.
- The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of CTS CORP.
Sentiment
Score: 5
Explanation: A Schedule 13G filing is a factual report of beneficial ownership and does not inherently convey positive or negative sentiment regarding the issuer's performance or prospects.
Positives
- NA
Negatives
- NA
Risks
- NA
Future Outlook
NA
Management Comments
- The securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §§ 240.14a-11.
Industry Context
NA
Comparison to Industry Standards
- NA
Stakeholder Impact
- Shareholders: Provides transparency regarding a significant institutional investor's stake, potentially signaling continued confidence in CTS CORP by T. Rowe Price Investment Management, Inc.
Key Dates
| Date | Description |
|---|---|
| 09/30/2025 | Date of event requiring the filing of this statement |
| 11/14/2025 | Signature date of the filing |
Keywords
CTS CORP, T. Rowe Price, Investment Management, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.